scholarly journals Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome

Critical Care ◽  
2015 ◽  
Vol 19 (Suppl 1) ◽  
pp. P329
Author(s):  
J Walle ◽  
S Johnson ◽  
E Harvey ◽  
J Kincaid
Sign in / Sign up

Export Citation Format

Share Document